Post-Exposure Prophylaxis with a monoclonal antibody cocktail Following Bundibugyo Ebolavirus Exposure in Adults and Children
Nature Medicine, Published online: 24 August 2026; doi:10.1038/s41591-026-04664-4 In a case series of an adult and four children with high- to intermediate-risk exposure to Bundibugyo ebolavirus, emergency use post-exposure prophylaxis monoclonal antibody cocktail (MBP134) treatment was well tolerated with no evidence of Bundibugyo virus disease, supporting future evaluation of MBP134 as a…
We haven't written up this one. Nature Medicine has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
